Currently, Pulse Biosciences Inc [PLSE] is trading at $15.54, down -0.13%. An important factor to consider is whether the stock is rising or falling in short-term value. The PLSE shares have lost -8.86% over the last week, with a monthly amount glided 3.46%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pulse Biosciences Inc [NASDAQ: PLSE] stock has seen the most recent analyst activity on July 07, 2025, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $22. Previously, Stephens started tracking the stock with Overweight rating on July 27, 2021, and set its price target to $28. On March 11, 2021, Maxim Group initiated with a Buy rating and assigned a price target of $40 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $40 on January 26, 2021. H.C. Wainwright upgraded its rating to a Buy and raised its price target to $16 on May 12, 2020. H.C. Wainwright downgraded its rating to Neutral for this stock on February 14, 2020, and downed its price target to $6. In a note dated February 25, 2019, H.C. Wainwright initiated an Buy rating and provided a target price of $27 on this stock.
This stock has fluctuated between a low of $13.77 and a high of $25.00 over the last 52 weeks. Pulse Biosciences Inc [NASDAQ: PLSE] shares were valued at $15.54 at the most recent close of the market.
Analyzing the PLSE fundamentals
Gross Profit Margin for this corporation currently stands at 0.17% with Operating Profit Margin at -43.41%, Pretax Profit Margin comes in at -40.88%, and Net Profit Margin reading is -40.88%. To continue investigating profitability, this company’s Return on Assets is posted at -0.57, Equity is -0.65 and Total Capital is -0.65. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.31 points at the first support level, and at 15.09 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.76, and for the 2nd resistance point, it is at 15.99.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Pulse Biosciences Inc [NASDAQ:PLSE] is 12.05. On the other hand, the Quick Ratio is 12.04, and the Cash Ratio is 11.85.
Transactions by insiders
Recent insider trading involved UECKER DARRIN, Chief Technology Officer, that happened on Jun 12 ’25 when 15000.0 shares were sold. Chief Technology Officer, UECKER DARRIN completed a deal on Jun 13 ’25 to sell 15000.0 shares. Meanwhile, Officer DARRIN UECKER bought 15000.0 shares on Jun 13 ’25.
